Dr. Zelenko’s Prescription for COVID-19

PROPHYLAXIS

TREATMENT

LINK: TheZelenkoProtocol.com


LINK: COVID Care Protocol from Eastern Virginia Medical School
The latest complete treatment protocol for doctors provided by Eastern Virginia Medical School, but does not include Hydroxychloroquine.


FROM NIH.GOV:

LINK: COVID-19 Treatment Guidelines

LINK: Corticosteroids (Including Dexamethasone)

NIH.GOV Recommendation for Patients with COVID-19

  • The COVID-19 Treatment Guidelines Panel (the Panel) recommends using dexamethasone (at a dose of 6 mg per day for up to 10 days) for the treatment of COVID-19 in patients who are mechanically ventilated (AI) and in patients who require supplemental oxygen but who are not mechanically ventilated (BI).
  • The Panel recommends against using dexamethasone for the treatment of COVID-19 in patients who do not require supplemental oxygen (AI).
  • LINK: Potential therapeutic effects of Dipyridamole in the severely ill patients with COVID-19

    Abstract

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. Effective antivirals with safe clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients with COVID-19, we found that hypercoagulability as indicated by elevated concentrations of D-dimers was associated with disease severity. By virtual screening of a U.S. FDA approved drug library, we identified an anticoagulation agent dipyridamole (DIP) in silico, which suppressed SARS-CoV-2 replication in vitro. In a proof-of-concept trial involving 31 patients with COVID-19, DIP supplementation was associated with significantly decreased concentrations of D-dimers (P < 0.05), increased lymphocyte and platelet recovery in the circulation, and markedly improved clinical outcomes in comparison to the control patients. In particular, all 8 of the DIP-treated severely ill patients showed remarkable improvement: 7 patients (87.5%) achieved clinical cure and were discharged from the hospitals while the remaining 1 patient (12.5%) was in clinical remission. KEY WORDS: Dipyridamole, SARS-CoV-2, COVID-19, Treatment, D-dimer, Severe cases


    LINK: Coronavirus: Air ionizers may be the key in fight to defeat Covid-19
    Swedish 2015 study used a portable air ionizing device to achieve 100% prevention of airborne transmitted influenza “A” between animals and a 97% inactivation of the virus.


    LINK: THE BRAZILIAN COVID KIT: Hydroxychloroquine, Azithromycin, Ivermectin, Zinc and Vitamin D for early treatment of Covid-19
    Regional Council of Medicine, Medical Association of Mato Grosso do Sul, Brazilian Medical Association, Union of Doctors

    IVERMECTIN and COVID-19

    Ivermectin does much more than just kill the virus.

    Ivermectin may interfere with the binding of the SARS-CoV-2 virus with the cell receptor on virus replication cells AND ON RED BLOOD CELLS, Reducing the blood clotting problem.

    Dr. Seheult explains:

    MORE ON IVERMECTIN:

    LINK: National University Singapore Launches Large COVID-19 Prophylaxis Study Targeting Ivermectin & HCQ

    LINK: PAPER: Ivermecin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2